Infection Due to Esbl Escherichia Coli

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-08-06
Clinical Trial Update: Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli [Phase 3]
Phase 3 trial comparing fosfomycin to meropenem or ceftriaxone for bacteremic infections due to multidrug-resistant ESBL-producing Escherich…